An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy oleh Jing Lin, Jing Lin, Jun Liu, Jun Liu, Shi-guang Hao, Bin Lan, Bin Lan, Xiao-bin Zheng, Jia-ni Xiong, Jia-ni Xiong, Ying-qian Zhang, Xuan Gao, Xuan Gao, Chuan-ben Chen, Chuan-ben Chen, Ling Chen, Ling Chen, Yu-fang Huang, Yu-fang Huang, Hong Luo, Hong Luo, Yu-ting Yi, Xin Yi, Jian-ping Lu, Jian-ping Lu, Xiong-wei Zheng, Xiong-wei Zheng, Gang Chen, Gang Chen, Xue-feng Wang, Xue-feng Wang, Xue-feng Wang, Yu Chen, Yu Chen